Pathogen: SARS-CoV-2

EuCARE-HOSPITALISED

Sweden Italy Poland Portugal Germany Lithuania United Kingdom Kenya Brazil Mexico
|
2022
  • Adults
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Blood sample
  • Nasopharyngeal swab
  • Urine sample

EuCARE-POSTCOVID

Italy Poland Portugal Lithuania Brazil Mexico Germany
|
2022
  • Adults
  • Hospital wide
  • Non-hospital health centre
  • Primary care
  • Emergency department
  • Long-term care facility
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • Nasopharyngeal swab

MERMAIDS 2

Serbia Estonia Greece Montenegro Italy Romania Spain The Netherlands
|
2022-2022
  • Adults
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Blood sample
  • Nasopharyngeal swab
  • Stool sample
  • PBMC
  • Serum
  • Whole blood

ORCHESTRA WP2 prospective cohort

France Italy Spain Congo Argentina The Netherlands
|
2020-2024
  • Adults
  • Hospital wide
  • Outpatient clinic
  • Primary care
  • Community
  • SARS-CoV-2
  • Post-COVID-19
  • Acute SARS-CoV-2
  • Blood sample
  • Nasopharyngeal swab
  • Stool sample
  • PBMC
  • Serum
  • Whole blood
  • Plasma

ADEQUATE

Serbia Belgium
|
2021-2025
  • Adults
  • Hospital wide
  • Emergency department
  • SARS-CoV-2
  • Acute SARS-CoV-2
  • Syndromic diagnostic testing

REACT

Spain Denmark South Africa
|
2022-2026
  • Adults
  • Hospital wide
  • Primary care
  • SARS-CoV-2
  • Influenza virus
  • Acute SARS-CoV-2
  • Influenza
  • Blood sample
  • PBMC
  • Serum
  • Whole blood
  • Plasma

SILENT 2

Belgium
|
2021-2023
  • Adults
  • General population
  • Elderly
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Solan

Spain
|
2022-2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

SOLIDARITY Finland Plus Long-COVID

Finland
|
2022-2025
  • Hospital wide
  • Intensive care unit
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Immnunomodulator
  • Antineoplastic agent
  • Imatinib
  • Infliximab

Steinmetz

Germany
|
2021
  • General population
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Stengel

Germany
|
2023
  • Adults
  • General population
  • Healthcare workers
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation